The Regulatory Mechanism and Research Progress of Ferroptosis in Gastric Cancer

被引:0
|
作者
Zhang, Zaibo [1 ]
Wang, Bingyu [1 ]
Liu, Wenbo [1 ]
Tan, Bibo [1 ,2 ]
机构
[1] Hebei Med Univ, Dept Surg 3, Hosp 4, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Dept Surg 3, Hosp 4, Shijiazhuang 050000, Peoples R China
关键词
ferroptosis; gastric cancer; lipid reactive oxygen species; biomarker; research status;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ferroptosis is a novel cell death modality discovered in recent years that is different from apoptosis and necrosis. It is usually associated with changes in the regulatory signaling in multiple organelles and depends on iron. It is caused by an imbalance between the generation and degradation of intracellular lipid reactive oxygen species (ROS). In addition to increased levels of cytoplasmic ROS and lipids, decreased mitochondrial volume and thickened mitochondrial membranes are markers of ferroptotic death. Gastric cancer is a common malignant tumor, but few studies on the possible role of ferroptosis in gastric cancer have been reported. Although ferroptosis is involved in multifactor-induced carcinogenesis, studies have also shown the role of ferroptosis in the selective killing of tumor cells, thereby inhibiting tumor progression and metastasis. In this paper, the definition, characteristics, and regulatory mechanism of ferroptosis and its potential role in gastric cancer are discussed. Therefore, this review is expected to provide a reference for the treatment of diseases based on ferroptosis and provide a direction for future research on the pathogenesis and development of gastric cancer and the development of anticancer drugs.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The Regulatory Mechanism and Research Progress of Ferroptosis in Gastric Cancer
    Zhang, Zaibo
    Wang, Bingyu
    Liu, Wenbo
    Tan, Bibo
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [2] Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases
    Wang, Xinyue
    Wei, Yanchen
    Wei, Fangyi
    Kuang, Haibin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [3] Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis
    Ge, Anqi
    He, Qi
    Zhao, Da
    Li, Yuwei
    Chen, Junpeng
    Deng, Ying
    Xiang, Wang
    Fan, Hongqiao
    Wu, Shiting
    Li, Yan
    Liu, Lifang
    Wang, Yue
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (01)
  • [4] The mechanism and progress of ferroptosis in pancreatic cancer
    Bao, Zhi-Hang
    Hou, Xiang-Bin
    Li, Hao-Ling
    Mao, Yi-Feng
    Wang, Wen-Rui
    ACTA HISTOCHEMICA, 2022, 124 (06)
  • [5] Ferroptosis and its current progress in gastric cancer
    Yue, Zhenqi
    Yuan, Yiwu
    Zhou, Qi
    Sheng, Jie
    Xin, Lin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [6] Research Progress of Ferroptosis Regulatory Network and Bone Remodeling in Osteoporosis
    Yan, Chunlu
    Zhang, Jinlong
    An, Fangyu
    Wang, Jiayu
    Shi, Yao
    Yuan, Lingqing
    Lv, Donghui
    Zhao, Yanzhen
    Wang, Yongfeng
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [7] Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma
    Ma, Meng
    Fei, Xifeng
    Jiang, Dongyi
    Chen, Hanchun
    Xie, Xiangtong
    Wang, Zhimin
    Huang, Qiang
    ONCOLOGY REVIEWS, 2024, 18
  • [8] Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC
    Yifan Zhang
    Ruixue Guo
    Jia Li
    Liangming Zhu
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 1 - 12
  • [9] Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC
    Zhang, Yifan
    Guo, Ruixue
    Li, Jia
    Zhu, Liangming
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (01) : 1 - 12
  • [10] Research progress on the mechanism of ferroptosis and its clinical application
    Xia, Jiarui
    Si, Huifang
    Yao, Wu
    Li, Chao
    Yang, Guo
    Tian, Yangyang
    Hao, Changfu
    EXPERIMENTAL CELL RESEARCH, 2021, 409 (02)